103 related articles for article (PubMed ID: 30707896)
21. Nuclear PKM2 expression predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zhang X; He C; He C; Chen B; Liu Y; Kong M; Wang C; Lin L; Dong Y; Sheng H
Pathol Res Pract; 2013 Aug; 209(8):510-5. PubMed ID: 23880164
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid-induced protein 3: identification and characterisation of a novel prognostic colon cancer biomarker.
Zougman A; Hutchins GG; Cairns DA; Verghese E; Perry SL; Jayne DG; Selby PJ; Banks RE
Eur J Cancer; 2013 Jan; 49(2):531-9. PubMed ID: 23021913
[TBL] [Abstract][Full Text] [Related]
23. A study of the immune infiltrate and patient outcomes in esophageal cancer.
Conroy MJ; Kennedy SA; Doyle SL; Hayes B; Kavanagh M; van der Stok EP; O'Sullivan K; Cathcart MC; Reynolds JV; Lysaght J
Carcinogenesis; 2021 Apr; 42(3):395-404. PubMed ID: 32940666
[TBL] [Abstract][Full Text] [Related]
24. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.
Sun Y; Wang J; Li Y; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Zhang X
Future Oncol; 2019 Jan; 15(2):121-132. PubMed ID: 30232909
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of CD9 correlates with tumor stage and lymph node metastasis in esophageal squamous cell carcinoma.
Huan J; Gao Y; Xu J; Sheng W; Zhu W; Zhang S; Cao J; Ji J; Zhang L; Tian Y
Int J Clin Exp Pathol; 2015; 8(3):3054-61. PubMed ID: 26045817
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
Wei R; Shang Z; Leng J; Cui L
J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
[TBL] [Abstract][Full Text] [Related]
27. Low expression of BEX1 predicts poor prognosis in patients with esophageal squamous cell cancer.
Geng HT; Cheng ZW; Cao RJ; Wang ZB; Xing SZ; Guo C; Wang F; Liu CM; Chen SS; Cheng YF
Oncol Rep; 2018 Nov; 40(5):2778-2787. PubMed ID: 30132532
[TBL] [Abstract][Full Text] [Related]
28. Stromal expression of JNK1 and VDR is associated with the prognosis of esophageal squamous cell carcinoma.
Bao Y; Zhang S; Guo Y; Wei X; Zhang Y; Yang Y; Zhang H; Ma M; Yang W
Clin Transl Oncol; 2018 Sep; 20(9):1185-1195. PubMed ID: 29423673
[TBL] [Abstract][Full Text] [Related]
29. TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.
Pham QT; Oue N; Sekino Y; Yamamoto Y; Shigematsu Y; Sakamoto N; Sentani K; Uraoka N; Yasui W
Oncology; 2018; 95(5):297-308. PubMed ID: 30134247
[TBL] [Abstract][Full Text] [Related]
30. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
31. High endothelin-converting enzyme-1 expression independently predicts poor survival of patients with esophageal squamous cell carcinoma.
Wu CF; Lee CT; Kuo YH; Chen TH; Chang CY; Chang IW; Wang WL
Tumour Biol; 2017 Sep; 39(9):1010428317725922. PubMed ID: 28945168
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of G9a and MCM7 in oesophageal squamous cell carcinoma is associated with poor prognosis.
Zhong X; Chen X; Guan X; Zhang H; Ma Y; Zhang S; Wang E; Zhang L; Han Y
Histopathology; 2015 Jan; 66(2):192-200. PubMed ID: 24805087
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
Liu Z; Yang T; Xu Z; Cao X
Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
[TBL] [Abstract][Full Text] [Related]
34. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of matrix metalloproteinase 10 is associated with poor survival in patients with early stage of esophageal squamous cell carcinoma.
Liu H; Qin YR; Bi J; Guo A; Fu L; Guan XY
Dis Esophagus; 2012; 25(7):656-63. PubMed ID: 22121946
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
Shi M; Wang Z; Liu XY; Chen D
Med Oncol; 2014 Dec; 31(12):309. PubMed ID: 25391920
[TBL] [Abstract][Full Text] [Related]
38. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
[TBL] [Abstract][Full Text] [Related]
40. CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis.
Uchi Y; Takeuchi H; Matsuda S; Saikawa Y; Kawakubo H; Wada N; Takahashi T; Nakamura R; Fukuda K; Omori T; Kitagawa Y
BMC Cancer; 2016 Jul; 16():514. PubMed ID: 27439769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
